GSK News

UK fraud office expects decision on GSK, Rolls-Royce cases next year

David Green, the head of the UK Serious Fraud Office, told Reuters in an interview that he hoped a decision about charges would be made before he steps down after six years in the job next April.

GSK, Pfizer other global pharma companies too come under USFDA net

Not all FDA regulatory action is targeted at Indian drug makers; global pharma majors fined too.


GSK recalls weight-loss drug in US on tampering concerns

The British group said it believed that some US bottles of Alli might not contain authentic product.

Maruti to focus on rural market

Maruti Suzuki India (MSI) is driving into the rural markets to boost sales.

GSK to spend $1 bn to hike stake in India unit

GSK is planning to hike its stake in the Indian unit to up to 75 per cent from 50.67 per cent.

Quarterly results: GSK Consumer Q3 net up 14.29%

GSK reported 14.29 per cent increase in standalone net profit at Rs 146.93 crore.


GlaxoSmithKline Pharma hit by Nomura downgrade

GlaxoSmithKline Pharmaceuticals Ltd shares dropped 4.3 per cent.

Consumer sector: Premium rush

Rural income growth and aspirational buys of lower income groups to sustain growth momentum.

WADA ties up with GSK to in order to catch dope cheats

WADA mostly has access to scientific information relating to medicines which have been licensed.